Mechanisms of Action of Estrogen in the Brain: Insights from Human Neuroimaging and Psychopharmacologic Studies

ABSTRACT

Use of estrogen therapy in the perimenopausal and postmenopausal periods has been shown in several clinical trials to help women maintain a premenopausal level of cognitive function. What is not yet fully understood is how the neurobiological effects of estrogen contribute to these cognitive effects. This review explores data from two related bodies of human literature that provide compelling evidence in support of the biological plausibility that estrogen treatment can benefit cognition. The first half of the literature review focuses on studies from the estrogen neuroimaging literature, and the second half focuses on pharmacologic challenge studies assessing estrogen-neurotransmitter interactions. We integrate these two bodies of literature by focusing on the neurophysiologic underpinnings of estrogen effects on cognition and linking these clinical studies to preclinical studies. The focus on verbal memory is important because it is a cognitive function that has been shown to change with estrogen treatment and predict Alzheimer's disease risk but is not addressed by preclinical studies. Overall, we conclude that estrogen interacts with cholinergic and serotonergic systems to affect hippocampal and frontal cortical brain areas and thereby enhance memory, particularly at the retrieval stage.

KEYWORDS

Estrogen - brain - cognition - psychopharmacology - neuroimaging

REFERENCES

• 1 Duka T, Tasker R, McGowan J F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.  Psychopharmacology (Berl). 2000;  149 129-139
• 2 Resnick S M, Metter E J, Zonderman A B. Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect?.  Neurology. 1997;  49 1491-1497
• 3 Jacobs D M, Tang M X, Stern Y et al.. Cognitive function in nondemented older women who took estrogen after menopause.  Neurology. 1998;  50 368-373
• 4 Smith Y R, Giordani B, Lajiness-O'Neill R, Zubieta J. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women.  Fertil Steril. 2001;  76 1101-1107
• 5 Maki P M, Zonderman A, Resnick S. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy.  Am J Psychiatry. 2001;  158 227-233
• 6 Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.  Am J Med. 2002;  113 543-548
• 7 Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.  Obstet Gynecol. 1998;  91 459-466
• 8 Binder E F, Schechtman K B, Birge S J, Williams D B, Kohrt W M. Effects of hormone replacement therapy on cognitive performance in elderly women.  Maturitas. 2001;  38 137-146
• 9 Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women.  JAMA. 1993;  269 2637-2641
• 10 Ditkoff E C, Crary W G, Cristo M, Lobo R A. Estrogen improves psychological function in asymptomatic postmenopausal women.  Obstet Gynecol. 1991;  78 991-995
• 11 Resnick S M, Coker L H, Maki P M, Rapp S R, Espeland M A, Shumaker S A. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.  Clin Trials. 2004;  1 440-450
• 12 Shumaker S, Legault C, Rapp S et al.. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial.  JAMA. 2003;  289 2651-2662
• 13 Ojemann J G, Akbudak E, Snyder A Z, McKinstry R C, Raichle M E, Conturo T E. Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts.  Neuroimage. 1997;  6 156-167
• 14 Sherwin B B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.  Psychoneuroendocrinology. 1988;  13 345-357
• 15 Sherwin B B, Tulandi T. “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.  J Clin Endocrinol Metab. 1996;  81 2545-2549
• 16 Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies.  J Cogn Neurosci. 2000;  12 1-47
• 17 Tulving E, Kapur S, Craik F I, Moscovitch M, Houle S. Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings.  Proc Natl Acad Sci U S A. 1994;  91 2016-2020
• 18 Tierney M C, Yao C, Kiss A, McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years.  Neurology. 2005;  64 1853-1859
• 19 Linzmayer L, Semlitsch H V, Saletu B et al.. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.  Arzneimittelforschung. 2001;  51 238-245
• 20 Joffe H, Hall J E, Gruber S et al.. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.  Menopause. 2006;  13 411-422
• 21 Resnick S M, Maki P M, Rapp S R et al.. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.  J Clin Endocrinol Metab. 2006;  91 1802-1810
• 22 Duff S J, Hampson E. A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy.  Horm Behav. 2000;  38 262-276
• 23 Resnick S M, Maki P M, Golski S, Kraut M A, Zonderman A B. Estrogen effects on PET cerebral blood flow and neuropsychological performance.  Horm Behav. 1998;  34 171-184
• 24 Maki P M, Resnick S M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition.  Neurobiol Aging. 2000;  21 373-383
• 25 Gleason C E, Schmitz T W, Hess T et al.. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation.  Neurology. 2006;  67 2039-2041
• 26 Shaywitz S E, Naftolin F, Zelterman D et al.. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen.  Menopause. 2003;  10 420-426
• 27 Maki P M, Gast M J, Vieweg A J, Burriss S W, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.  Neurology. 2007;  69 1322-1330
• 28 Shaywitz S E, Shaywitz B A, Pugh K R et al.. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.  JAMA. 1999;  281 1197-1202
• 29 Rasgon N L, Small G W, Siddarth P et al.. Estrogen use and brain metabolic change in older adults. A preliminary report.  Psychiatry Res. 2001;  107 11-18
• 30 Rasgon N L, Silverman D, Siddarth P et al.. Estrogen use and brain metabolic change in postmenopausal women.  Neurobiol Aging. 2005;  26 229-235
• 31 Small G W, Ercoli L M, Silverman D H et al.. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.  Proc Natl Acad Sci U S A. 2000;  97 6037-6042
• 32 Eberling J L, Reed B R, Coleman J E, Jagust W J. Effect of estrogen on cerebral glucose metabolism in postmenopausal women.  Neurology. 2000;  55 875-877
• 33 Eberling J L, Wu C, Tong-Turnbeaugh R, Jagust W J. Estrogen- and tamoxifen-associated effects on brain structure and function.  Neuroimage. 2004;  21 364-371
• 34 Roca C A, Schmidt P J, Altemus M et al.. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.  J Clin Endocrinol Metab. 2003;  88 3057-3063
• 35 Varney N R, Syrop C, Kubu C S, Struchen M, Hahn S, Franzen K. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism.  J Assist Reprod Genet. 1993;  10 53-57
• 36 Newton C, Slota D, Yuzpe A A, Tummon I S. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study.  Fertil Steril. 1996;  65 1253-1255
• 37 Berman K F, Schmidt P J, Rubinow D R et al.. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women.  Proc Natl Acad Sci U S A. 1997;  94 8836-8841
• 38 Grigorova M, Sherwin B B, Tulandi T. Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women.  Psychoneuroendocrinology. 2006;  31 935-947
• 39 Gibbs R B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.  Exp Neurol. 1998;  151 289-302
• 40 Bethea C L, Lu N Z, Gundlah C, Streicher J M. Diverse actions of ovarian steroids in the serotonin neural system.  Front Neuroendocrinol. 2002;  23 41-100
• 41 Morissette M, Sweidi S A, Callier S, Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease.  Mol Cell Endocrinol. 2008;  290 60-69
• 42 Guerra-Araiza C, Miranda-Martinez A, Neri-Gomez T, Camacho-Arroyo I. Sex steroids effects on the content of GAD, TH, GABA(A), and glutamate receptors in the olfactory bulb of the male rat.  Neurochem Res. 2008;  33 1568-1573
• 43 Woolley C S, McEwen B S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.  J Neurosci. 1994;  14 7680-7687
• 44 Luine V N, Khylchevskaya R I, McEwen B S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain.  Brain Res. 1975;  86 293-306
• 45 Luine V N, Renner K J, McEwen B S. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments.  Endocrinology. 1986;  119 874-878
• 46 Singh M, Meyer E M, Millard W J, Simpkins J W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats.  Brain Res. 1994;  644 305-312
• 47 Gibbs R B, Wu D, Hersh L B, Pfaff D W. Effects of estrogen replacement on the relative levels of choline acetytransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats.  Exp Neurol. 1994;  129 70-80
• 48 Tinkler G P, Tobin J R, Voytko M L. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys.  J Comp Neurol. 2004;  469 507-521
• 49 Kritzer M, Kohama S. Ovarian hormones differentially influence immunoreactivity for dopamine beta-hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkey.  J Comp Neurol. 1999;  409 438-451
• 50 Voytko M L. Estrogen and the cholinergic system modulate visuospatial attention in monkeys (Macaca fascicularis).  Behav Neurosci. 2002;  116 187-197
• 51 Tinkler G P, Voytko M L. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys.  Prog Neuropsychopharmacol Biol Psychiatry. 2005;  29 423-431
• 52 Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women.  Neuropsychopharmacology. 2006;  31 2065-2078
• 53 Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis.  Horm Behav. 2008;  53 159-169
• 54 Norbury R, Travis M J, Erlandsson K, Waddington W, Ell P J, Murphy D G. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study.  Horm Behav. 2007;  51 249-257
• 55 Sunderland T, Tariot P N, Weingartner H et al.. Pharmacologic modelling of Alzheimer's disease.  Prog Neuropsychopharmacol Biol Psychiatry. 1986;  10 599-610
• 56 Resnick S M, Henderson V W. Hormone therapy and risk of Alzheimer disease: a critical time.  JAMA. 2002;  288 2170-2172
• 57 Maki P M. Hormone therapy and cognitive function: is there a critical period for benefit?.  Neuroscience. 2006;  138 1027-1030
• 58 Sherwin B B. Estrogen and cognitive aging in women.  Neuroscience. 2006;  138 1021-1026
• 59 Sherwin B B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature.  J Neuroendocrinol. 2007;  19 77-81
• 60 Markowska A L, Savonenko A V. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats.  J Neurosci. 2002;  22 10985-10995
• 61 van Amelsvoort T A, Abel K M, Robertson D M et al.. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.  Psychoneuroendocrinology. 2001;  26 493-502
• 62 Riedel W J, Klaassen T, Schmitt J A. Tryptophan, mood, and cognitive function.  Brain Behav Immun. 2002;  16 581-589
• 63 Amin Z, Gueorguieva R, Cappiello A et al.. Estradiol and tryptophan depletion interact to modulate cognition in menopausal women.  Neuropsychopharmacology. 2006;  31 2489-2497
• 64 Compton J, Travis M J, Norbury R et al.. Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study.  Horm Behav. 2008;  53 61-68
• 65 Kugaya A, Epperson C N, Zoghbi S et al.. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.  Am J Psychiatry. 2003;  160 1522-1524
• 66 Amin Z, Epperson C N, Constable R T, Canli T. Effects of estrogen variation on neural correlates of emotional response inhibition.  Neuroimage. 2006;  32 457-464